Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin

Journal of the American Academy of Dermatology

Volumn 58, Issue 3, 2008, Pages 512-515

  Davis, Mark D P ^a   Wysokinski, Waldemar E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; PENTOXIFYLLINE; PROTHROMBIN; STANOZOLOL; WARFARIN;

ADULT; ARTICLE; CASE REPORT; DRUG RESPONSE; FEMALE; GENE MUTATION; HETEROZYGOTE; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL; SKIN ULCER; THROMBOSIS; TOPICAL TREATMENT; VASCULAR DISEASE; WOUND CARE;

ANTICOAGULANTS; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; LEG ULCER; LIVEDO RETICULARIS; MIDDLE AGED; MUTATION; PROTHROMBIN; SKIN DISEASES, VASCULAR; THROMBOPHILIA; WARFARIN;

EID: 38949099044     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.087     Document Type: Article

References (24)

1. Browning C.E., and Callen J.P. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 142 (2006) 75-78
2. Klein K.L., and Pittelkow M.R. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67 (1992) 923-933
3. Schroeter A.L., Diaz-Perez J.L., Winkelmann R.K., and Jordan R.E. Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol 111 (1975) 188-193
4. Gibson G.E., Li H., and Pittelkow M.R. Homocystinemia and livedoid vasculitis. J Am Acad Dermatol 40 (1999) 279-281
5. Calamia K.T., Balabanova M., Perniciaro C., and Walsh J.S. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 46 (2002) 133-137
6. Boyvat A., Kundakci N., Babikir M.O., and Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 143 (2000) 840-842
7. Acland K.M., Darvay A., Wakelin S.H., and Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?. Br J Dermatol 140 (1999) 131-135
8. Pizzo S.V., Murray J.C., and Gonias S.L. Atrophie blanche: a disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 110 (1986) 517-519
9. Hairston B.R., Davis M.D., Gibson L.E., and Drage L.A. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 139 (2003) 987-990
10. Frances C., and Barete S. Difficult management of livedoid vasculopathy. [letter]. Arch Dermatol 140 (2004) 1011
11. Drucker C.R., and Duncan W.C. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 7 (1982) 359-363
12. Sauer G.C. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. [letter]. Arch Dermatol 122 (1986) 380-381
13. Hsiao G.H., and Chiu H.C. Low-dose danazol in the treatment of livedoid vasculitis. Dermatology 194 (1997) 251-255
14. Wakelin S.H., Ellis J.P., and Black M.M. Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol. [letter]. Br J Dermatol 139 (1998) 935-937
15. Jetton R.L., and Lazarus G.S. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 8 (1983) 23-26
16. Winkelmann R.K., Schroeter A.L., Kierland R.R., and Ryan T.M. Clinical studies of livedoid vasculitis (segmental hyalinizing vasculitis). Mayo Clin Proc 49 (1974) 746-750
17. Rustin M.H., Bunker C.B., and Dowd P.M. Chronic leg ulceration with livedoid vasculitis and response to oral katanserin. Br J Dermatol 120 (1989) 101-105
18. Lee J.H., Choi H.J., Kim S.M., Hann S.K., and Park Y.K. Livedoid vasculitis responding to PUVA therapy. Int J Dermatol 40 (2001) 153-157
19. Yang C.H., Ho H.C., Chan Y.S., Liou L.B., Hong H.S., and Yang L.C. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen. Br J Dermatol 149 (2003) 647-652
20. Kreuter A., Gambichler T., Breuckmann F., Bechara F.G., Rotterdam S., Stucker M., et al. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients. J Am Acad Dermatol 51 (2004) 574-579
21. Magy N., Algros M.P., Racadot E., Gil H., Kantelip B., and Dupond J.L. Livedoid vasculopathy with combined thrombophilia: efficacy of iloprost. [in French]. Rev Med Interne 23 (2002) 554-557
22. Lee S.S., Ang P., and Tan S.H. Clinical profile and treatment outcome of livedoid vasculitis: a case series. Ann Acad Med Singapore 32 (2003) 835-839
23. Yang L.J., Chan H.L., Chen S.Y., Kuan Y.Z., Chen M.J., Wang C.N., et al. Atrophie blanche: a clinicopathological study of 27 patients. Changgeng Yi Xue Za Zhi 14 (1991) 237-245
24. Davis M.D.P., and Adams A. Lidocaine patch for the management of leg ulcer pain. J Am Acad Dermatol 55 Suppl (2006) S126-S127